| 000 | 02524 a2200709 4500 | ||
|---|---|---|---|
| 005 | 20250517003609.0 | ||
| 264 | 0 | _c20160328 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.2583 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChilà, Rosaria | |
| 245 | 0 | 0 |
_aCombined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma. _h[electronic resource] |
| 260 |
_bOncotarget _cFeb 2015 |
||
| 300 |
_a3394-408 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xgenetics |
| 650 | 0 | 4 |
_aBenzodiazepinones _xpharmacology |
| 650 | 0 | 4 | _aCDC2 Protein Kinase |
| 650 | 0 | 4 |
_aCell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCheckpoint Kinase 1 |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase 2 _xgenetics |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinases _xgenetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aLymphoma, Mantle-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aNuclear Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinases _xgenetics |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 | _aPyrimidinones |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aBasana, Alessandra | |
| 700 | 1 | _aLupi, Monica | |
| 700 | 1 | _aGuffanti, Federica | |
| 700 | 1 | _aGaudio, Eugenio | |
| 700 | 1 | _aRinaldi, Andrea | |
| 700 | 1 | _aCascione, Luciano | |
| 700 | 1 | _aRestelli, Valentina | |
| 700 | 1 | _aTarantelli, Chiara | |
| 700 | 1 | _aBertoni, Francesco | |
| 700 | 1 | _aDamia, Giovanna | |
| 700 | 1 | _aCarrassa, Laura | |
| 773 | 0 |
_tOncotarget _gvol. 6 _gno. 5 _gp. 3394-408 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.2583 _zAvailable from publisher's website |
| 999 |
_c24384211 _d24384211 |
||